HOUSTON, March 8, 2022 /PRNewswire/ — Vivante Health, the leading digital solution for digestive health and disease, has announced a $16 million Series A funding round led by 7wireVentures. The financing round was joined by new investors Human Capital, Intermountain Ventures, SemperVirens, Elements Health Ventures, and Leaps by Bayer. Returning investors FCA Venture Partners, NFP Ventures, Lifeforce Capital, and Big Pi Ventures also participated in the round.
Since the beginning of 2021, Vivante Health has grown the company’s client base by 400% through the addition of key Fortune 500 clients that join existing clients such as US Foods, Bucknell University, and Marpai. The company’s commercial expansion is bolstered by partnerships with best-in-class employer healthcare solutions such as Virgin Pulse and Accolade. Collectively, Vivante’s potential member base encompasses over 500,000 covered lives. The company’s continued commercial momentum speaks to the significant opportunity to service the growing employer demand for digestive health solutions.
“The Series A financing round represents another pivotal milestone in our mission to improve our member’s digestive health and provide outcomes at scale for our enterprise partners,” said Bill Snyder, Vivante Health CEO. “We are thrilled to partner with premier investors in this latest round of funding that will enable us to continue our rapid growth trajectory and further establish ourselves as the leader in digestive health.”